A/Prof Jonathan Payne
A/Prof Jonathan Payne
Details
Role
Co-Grp Leader/Principal Research Fellow
Research area
Clinical sciences
Group
Brain and Mind
Contact
Email
show email address
Associate Professor Jonathan Payne is co-lead of the Brain & Mind Research Group at the Murdoch Children's Research Institute, where he leads the Genetics and Neurodevelopment Team and sits on the steering committee of the Neurodevelopment Flagship. He is a practicing senior clinical neuropsychologist at the Royal Children's Hospital and an Honorary Principal Research Fellow in the Department of Paediatrics, University of Melbourne.
Associate Professor Payne's research draws on a range of cognitive, behavioural, neuroimaging, and laboratory protocols to understand how genetic variants can affect brain development and increase the risk for neurodevelopmental disorders. He is also an experienced trialist and leads several pharmacological and non-pharmacological clinical trials.
Associate Professor Payne's research draws on a range of cognitive, behavioural, neuroimaging, and laboratory protocols to understand how genetic variants can affect brain development and increase the risk for neurodevelopmental disorders. He is also an experienced trialist and leads several pharmacological and non-pharmacological clinical trials.
Associate Professor Jonathan Payne is co-lead of the Brain & Mind Research Group at the Murdoch Children's Research Institute, where he leads the Genetics and Neurodevelopment Team and sits on the steering committee of the Neurodevelopment Flagship....
Associate Professor Jonathan Payne is co-lead of the Brain & Mind Research Group at the Murdoch Children's Research Institute, where he leads the Genetics and Neurodevelopment Team and sits on the steering committee of the Neurodevelopment Flagship. He is a practicing senior clinical neuropsychologist at the Royal Children's Hospital and an Honorary Principal Research Fellow in the Department of Paediatrics, University of Melbourne.
Associate Professor Payne's research draws on a range of cognitive, behavioural, neuroimaging, and laboratory protocols to understand how genetic variants can affect brain development and increase the risk for neurodevelopmental disorders. He is also an experienced trialist and leads several pharmacological and non-pharmacological clinical trials.
Associate Professor Payne's research draws on a range of cognitive, behavioural, neuroimaging, and laboratory protocols to understand how genetic variants can affect brain development and increase the risk for neurodevelopmental disorders. He is also an experienced trialist and leads several pharmacological and non-pharmacological clinical trials.
Top Publications
- Maier, A, Pride, NA, Hearps, SJC, Shah, N, Porter, M, North, KN, Payne, JM. Neuropsychological factors associated with performance on the rey-osterrieth complex figure test in children with neurofibromatosis type 1.. Child Neuropsychol 1 -12 2023 view publication
- Hocking, DR, Sun, X, Haebich, K, Darke, H, North, KN, Vivanti, G, Payne, JM. Delineating Visual Habituation Profiles in Preschoolers with Neurofibromatosis Type 1 and Autism Spectrum Disorder: A Cross-Syndrome Study. Journal of Autism and Developmental Disorders 1 -14 2023 view publication
- Zendarski, N, Galligan, R, Coghill, D, Payne, JM, De Luca, CR, Mulraney, M. The Associations between Child Irritability, Parental Distress, Parental Irritability and Family Functioning in Children Accessing Mental Health Services. Journal of Child and Family Studies 32(1) : 288 -300 2022 view publication
- de Blank, PMK, Gross, AM, Akshintala, S, Blakeley, JO, Bollag, G, Cannon, A, Dombi, E, Fangusaro, J, Gelb, BD, Hargrave, D, et al. MEK inhibitors for neurofibromatosis type 1 manifestations: Clinical evidence and consensus.. Neuro-Oncology 24(11) : 1845 -1856 2022 view publication
- Rance, G, Maier, A, Zanin, J, Haebich, KM, North, KN, Orsini, F, Dabscheck, G, Delatycki, MB, Payne, JM. A randomized controlled trial of remote microphone listening devices to treat auditory deficits in children with neurofibromatosis type 1. Neurological Sciences 43(9) : 5637 -5641 2022 view publication
Page 1 of 14
Professional activities
Share //
